title: Epithelial-mesenchymal transition in prostate cancer: providing new targets for therapy.
authors.affiliation: Duke Cancer Institute, Department of Medicine, Duke Prostate Center, Duke University, Durham, NC 27710, USA. andrew.armstrong@duke.edu
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Armstrong
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Freedland
authors.forename: Mariano
authors.initials: M
authors.lastname: Garcia-Blanco
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000235:genetics / Q000502:physiology; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D015820:Cadherins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D058750:Epithelial-Mesenchymal Transition / Q000502:physiology; D055785:Gene Knockdown Techniques; D006801:Humans; D008297:Male; D051379:Mice; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy
chemical_list: D015703:Antigens, CD; D014408:Biomarkers, Tumor; C050361:CDH2 protein, human; D015820:Cadherins